Michigan’s experience demonstrates a way for governments to increase immunization rates without having to address religious or philosophical opposition to vaccines.

Critics say vulnerable patients are being manipulated and the goals promoted are skewed by the pharma benefactors who want faster government approval for new products.

Cell Press announces its new preprint server, Donald Trump has yet to name a science advisor, and new gene-editing tools are calling an old finding into question.

In his new book, journalist Richard Harris writes that lack of reproducibility in research poses a serious threat to science.

Scientists in the United Kingdom react to the reality of Brexit, a U.S. Supreme Court nominee apologizes for ruling against the family of a boy with autism, and a Rett syndrome researcher is racking up awards.

Young adults with autism face many new expectations and challenges — with none of the support that is available during high school.

Clashing visions for the March for Science are muddying the event’s message, biomedical funding cuts do not put America first, and a rule restricting research on human embryos needs a revamp.

Acting on a request from three influential U.S. senators, the government’s accountability arm confirmed that it will investigate potential abuses of the Orphan Drug Act.

President Trump’s spending plan — running into opposition from Republicans and Democrats alike — would cut about 20 percent of the roughly $30 billion budget of the U.S. medical research agency.

Donald Trump’s budget blueprint calls for considerable cuts to science agencies, CRISPR corrects mutations in human embryos, and a documentary highlights the challenges faced by an adult with autism.